MarqVision: Why AI-Powered Brand Protection Is Becoming a Patient-Safety Imperative for Pharma

Overview: How MarqVision’s AI-Driven Online Brand Protection and Counterfeit Enforcement Platform Transforms Pharmaceutical Brand Integrity and Patient Safety

MarqVision is an AI-driven online brand protection and counterfeit-enforcement platform that helps pharmaceutical companies identify, report, and remove suspected counterfeit medicines, unauthorised sales, and brand impersonation across digital channels and supply networks. It addresses a persistent healthcare bottleneck: counterfeit products can spread rapidly through global marketplaces and social media, making manual monitoring fragmented and too slow to provide a coordinated view of emerging threats. These products can expose patients to incorrect doses, harmful ingredients, or treatments with no active ingredient, while also eroding trust in legitimate therapies.

The platform applies AI-powered detection to scan global marketplaces and related channels for potentially infringing listings and patterns, then supports structured reporting and removal workflows. MarqVision also combines online intelligence with source-level investigations intended to trace counterfeit activity back through distribution pathways and production networks. This gives brand-protection, operations, and product-security teams a more consolidated way to prioritise incidents, coordinate enforcement activity, and assess where risks are most concentrated.

By reducing the manual effort required to find and triage suspicious listings, MarqVision can shorten the time between detection and response while improving visibility into the scale and recurrence of illicit activity. The company reports AI-driven detection that is up to 10 times faster than manual enforcement and a takedown success rate above 95% across global e-commerce platforms; actual results will depend on the product portfolio, market coverage, and channel mix.

Last checked on August 24, 2026: MarqVision remains active and has recently expanded Marq AI with automated, human-reviewed rapid takedowns for brand impersonation across domains, paid ads, and website content.

What is MarqVision?

MarqVision is an AI-powered online brand-protection and counterfeit-enforcement platform for pharmaceutical companies, used to detect, report, and seek removal of suspected counterfeit medicines, unauthorised sales, and impersonation across e-commerce, social-media, and supply-chain channels. It is designed for pharmaceutical brand-protection, product-security, legal, and operational teams, not clinical care or research users. Its approach combines AI-supported online detection with marketplace relationships and offline investigations into suspected production and distribution sources; MarqVision reports a 95%+ e-commerce takedown success rate and detection up to 10 times faster than manual enforcement, though these are company-reported figures.

Why Do Leading Healthcare Teams Trust MarqVision?

• MarqVision maintains a dedicated pharmaceutical offering for detecting and seeking removal of suspected counterfeit drugs across e-commerce, social media, and supply-chain channels.

• The company’s public privacy policy, effective February 2, 2026, describes technical, organisational, and administrative safeguards and provides a process for GDPR data-subject requests.

• No FDA clearance, CE marking, HIPAA attestation, or ISO/SOC certification was identified in the reviewed public materials; buyers should request current evidence directly during procurement.

• MarqVision announced a $48 million Series B financing in September 2025, led by Peak XV with participation from HSG, Salesforce Ventures, Coral Capital, and Y Combinator affiliates.

• The Series B brought the company’s stated total funding to $90 million and supported continued development of AI-powered brand-protection and enforcement capabilities.

• MarqVision was named an Inc. 5000 honoree in 2025, according to its press page.

• Public company materials cite an LVMH Innovation Award; this recognition is relevant to its broader brand-protection technology but is not healthcare-specific.

• MarqVision publicly identifies Integrative Therapeutics as a customer example, describing use of AI-supported monitoring and enforcement for counterfeit and impersonation risks in the supplement sector.

• The company states it works with more than 130 marketplace and platform partners, including Amazon, TikTok Shop, and Walmart, to support enforcement workflows; this claim is company-reported.

• No merger, acquisition, or corporate ownership change was identified in the reviewed recent news and company materials.